BioCentury
ARTICLE | Financial News

Arix raises L100M in IPO

February 17, 2017 10:26 PM UTC

Investment firm Arix Bioscience plc (LSE:ARIX) raised L100 million ($125.2 million) through the sale of 48.3 million shares at 207p in an IPO underwritten by Jefferies. The offering values the company at L187 million ($234 million). Investors included Woodford Investment Management, UCB Group (Euronext:UCB) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). The company expects its shares to begin regular trading on Feb. 22.

The firm plans to invest in both start-up and later-stage healthcare and life science companies worldwide. Its portfolio includes Autolus Ltd. (London, U.K.), Depixus S.A.S. (Paris, France), OptiKira LLC (Cleveland, Ohio), Verona Pharma plc (LSE:VRP) and Artios Pharma Ltd. (Cambridge, U.K.)...